Mikhail Blagosklonny is a successful scientist who has done significant research on aging and cancer. He is also a top professor of oncology and has been working at the Roswell Park Cancer Institute since 2009. Mikhail Blagosklonny completed his masters in internal medicine from the First Pavlov State Medical University of St. Petersburg. He later enrolled at the university to pursue his Ph.D. in experimental medicine and cardiology. Mikhail joined the New York Medical College in 2002 and served it as an associate professor. The Ordway Research Institute later offered him a chance to be its senior scientist before taking his role at the Roswell Park Cancer Institute. The professor had earned sufficient knowledge from the organization that he served and has made significant contributions at the institute. He has researched fields such as cancer, biogerontology, and anti-aging. Blagosklonny has also been involved in the development of targeted cancer therapies that are not harmful to healthy body cells.
The professor has been hired by Oncotarget to serve as its editor-in-chief. He has also focused on therapy and cancer biology and is an associate editor in the fields. Mikhail has sufficient knowledge of cell differentiation and death. He has researched how aging and cancer can be influenced by TOR signaling. The scientist has proposed that Rapamycin can be an excellent cure for cancer and many other life-threatening conditions. He believes that the drug has unique properties that enable it to lengthen people’s lives. Other fields that Blagosklonny has specialized in include cellular biology, molecular biology, and clinical investigations. His research has covered different fields that include mitosis, tumor suppressors, signal transduction, ontogenesis, anticancer therapeutics, ontogenesis, and apoptosis.
Blagosklonny has currently published a lot of informative work that focuses on the aging hyperfunction theory. His publications have covered cell chemotherapeutic and cyclotherapy engineering. He is respected in the medical research field due to his knowledge of oncology. Mikhail thinks that it is not impossible for medical professionals to control both aging and cancer. He believes that various cancers can be cured by using Rapamycin. In his career, the scientist has managed to write over 300 book chapters, reviews, articles, and book chapters. Various organizations have hired him to act as an associate editor, and they include PLOS ONE, International Journal of Cancer, and the American Journal of Pathology. Blogosklonny is passionate about the cancer research field and is recognized as one of the world’s leading oncology experts. He believes that his career is greatly inspired by his love for humanity and dedication to transform the world into a disease-free place.
The scientist’s accomplishments at the Roswell Park Cancer Institute are appreciated. At the organization, he has worked with many oncology experts and shared ideas on how cancer can be eliminated permanently. Mikhail has been focused on discovering how cancer can be prevented by slowing down aging. According to him, the two condition are related since old people have high chances of having the deadly disease. He believes that preventing aging can be a significant step towards controlling cancer.